GLB1 and nervous system disorder: These results match previous investigations, stating an onset of clinical signs around the age of approximately 4 months35, 42 in GM1‐gangliosidosis and an ‘increasing neurological disorder starting at the age of 3.5–4 months’ in Glb1−/− mice.40